Axon Enterprise, Inc. (NASDAQ:AXON) Holdings Raised by Two Sigma Advisers LP

Two Sigma Advisers LP grew its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 144.7% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 66,800 shares of the biotechnology company’s stock after acquiring an additional 39,500 shares during the period. Two Sigma Advisers LP owned 0.09% of Axon Enterprise worth $26,693,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of AXON. Massachusetts Financial Services Co. MA purchased a new position in Axon Enterprise in the third quarter valued at about $120,553,000. International Assets Investment Management LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $871,860,000. Westfield Capital Management Co. LP grew its stake in shares of Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares in the last quarter. 1832 Asset Management L.P. increased its holdings in Axon Enterprise by 44.0% in the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after buying an additional 114,800 shares during the last quarter. Finally, Champlain Investment Partners LLC raised its position in Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after acquiring an additional 83,265 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC raised their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. JMP Securities upped their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday. Finally, Northland Securities boosted their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $488.67.

Axon Enterprise Stock Performance

AXON opened at $687.69 on Friday. The stock’s 50 day simple moving average is $516.24 and its 200-day simple moving average is $393.00. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market cap of $52.44 billion, a PE ratio of 177.70, a P/E/G ratio of 15.13 and a beta of 1.01. Axon Enterprise, Inc. has a 1 year low of $232.78 and a 1 year high of $698.67.

Insider Buying and Selling at Axon Enterprise

In other news, CFO Brittany Bagley sold 4,338 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total value of $1,643,885.10. Following the sale, the chief financial officer now directly owns 98,825 shares in the company, valued at approximately $37,449,733.75. This represents a 4.20 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 8,182 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $364.86, for a total value of $2,985,284.52. Following the transaction, the insider now owns 176,228 shares of the company’s stock, valued at $64,298,548.08. This trade represents a 4.44 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 137,921 shares of company stock valued at $63,093,907 in the last 90 days. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.